Aligned Genetics Inc (238120) - Total Assets
Based on the latest financial reports, Aligned Genetics Inc (238120) holds total assets worth ₩45.11 Billion KRW (≈ $30.57 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Aligned Genetics Inc for net asset value and shareholders' equity analysis.
Aligned Genetics Inc - Total Assets Trend (2015–2024)
This chart illustrates how Aligned Genetics Inc's total assets have evolved over time, based on quarterly financial data.
Aligned Genetics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Aligned Genetics Inc's total assets of ₩45.11 Billion consist of 57.8% current assets and 42.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩1.81 Billion | 18.8% |
| Accounts Receivable | ₩2.89 Billion | 6.5% |
| Inventory | ₩4.20 Billion | 9.5% |
| Property, Plant & Equipment | ₩7.77 Billion | 17.6% |
| Intangible Assets | ₩131.53 Million | 0.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Aligned Genetics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 238120 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aligned Genetics Inc's current assets represent 57.8% of total assets in 2024, a decrease from 84.5% in 2015.
- Cash Position: Cash and equivalents constituted 18.8% of total assets in 2024, down from 47.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 8.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 17.6% of total assets.
Aligned Genetics Inc Competitors by Total Assets
Key competitors of Aligned Genetics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.54 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.72 Billion |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥1.42 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$15.57 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
Aligned Genetics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.05 | 17.95 | 13.07 |
| Quick Ratio | 8.13 | 14.10 | 11.34 |
| Cash Ratio | 0.00 | 1.94 | 0.00 |
| Working Capital | ₩23.63 Billion | ₩20.62 Billion | ₩14.72 Billion |
Aligned Genetics Inc - Advanced Valuation Insights
This section examines the relationship between Aligned Genetics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.66 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | ₩44.28 Billion |
| Market Capitalization | $41.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aligned Genetics Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aligned Genetics Inc's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aligned Genetics Inc (2015–2024)
The table below shows the annual total assets of Aligned Genetics Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩44.28 Billion ≈ $30.00 Million |
+8.17% |
| 2023-12-31 | ₩40.93 Billion ≈ $27.74 Million |
+10.92% |
| 2022-12-31 | ₩36.90 Billion ≈ $25.01 Million |
+7.06% |
| 2021-12-31 | ₩34.47 Billion ≈ $23.36 Million |
+35.27% |
| 2020-12-31 | ₩25.48 Billion ≈ $17.27 Million |
+3.50% |
| 2019-12-31 | ₩24.62 Billion ≈ $16.68 Million |
+7.04% |
| 2018-12-31 | ₩23.00 Billion ≈ $15.59 Million |
-5.37% |
| 2017-12-31 | ₩24.31 Billion ≈ $16.47 Million |
-6.01% |
| 2016-12-31 | ₩25.86 Billion ≈ $17.53 Million |
+277.04% |
| 2015-12-31 | ₩6.86 Billion ≈ $4.65 Million |
-- |
About Aligned Genetics Inc
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genet… Read more